3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Venous Thrombosis
3
Venous Thromboembolism
3
Neoplasms
3
Pancreatic Neoplasms
2
Venous Thormboembolism
1
Thrombosis
1
Thromboembolism
1
Stroke
1
Soft Tissue Neoplasms
1
Sarcoma
1
Pulmonary Embolism
1
Ovarian Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Catheter-Related Infections
1
Carcinoma, Pancreatic Ductal
1
Interventions
Cisplatin
75
Cetuximab
63
Radiotherapy
38
pembrolizumab
29
Radiotherapy, Intensity-Modulated
28
Carboplatin
25
Fluorouracil
24
Docetaxel
24
Paclitaxel
19
Erlotinib Hydrochloride
13
Nivolumab
12
Radiation
10
Pemetrexed
10
durvalumab
8
Gemcitabine
8
Drug Therapy
8
Bevacizumab
7
zalutumumab
6
Surgical Procedures, Operative
6
Panitumumab
6
Lapatinib
6
Everolimus
6
Albumin-Bound Paclitaxel
6
130-nm albumin-bound paclitaxel
6
epacadostat
5
Standard of Care
5
Oxaliplatin
5
Gefitinib
5
Afatinib
5
Radiosurgery
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Head and Neck Neoplasms
×
Enoxaparin
×
Clear all
No trials found.